2018 STEP Program™ designed to support unique proposals from nonprofit organizations that serve people living with sickle cell disease
EAST HANOVER, N.J., Nov. 14, 2018 /PRNewswire/ -- Novartis announced the launch of the 2018 STEP (Solutions to Empower Patients) Program™ to inspire solutions that support people living with sickle cell disease (SCD). Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8420351-novartis-2018-step-program/ The program will recognize and fund as many as five proposals of up to $50,000 each that demonstrate innovation in health education, empowerment and support to help improve the experience of people living with SCD. In 2017, the first year of the initiative, the STEP Program provided funding to three organizations involved with metastatic breast cancer. “People living with sickle cell disease face unique challenges,” said Ameet Mallik, Executive Vice President and Head, US, Novartis Oncology. “By helping fund innovative programs developed by the organizations that best understand these challenges, we hope to make the biggest impact for those affected by this disease, where there continues to be a significant unmet need.” Sickle cell disease is a genetic blood disorder that causes ongoing damage to blood vessels and organs1. It is a lifelong illness that can place emotional, physical and financial burdens on patients and their families as they navigate issues dealing with work, school, family and finances. People with SCD often experience recurrent episodes of acute, severe pain (called vaso-occlusive crises) which can eventually become chronic2. These crises are the main reason why patients go to the hospital and are linked to poor health outcomes and early death3. Application Details for Interested Health Care or Health Care-Related Nonprofit Organizations
Proposals will be evaluated by an external review committee consisting of experts in a variety of fields. The committee will review the applications and evaluate and identify as many as five proposals on the basis of innovation and the potential to make the greatest positive impact on the SCD community. Organizations that wish to apply for funding from the STEP Program should send their completed submission form to STEP.Program@Novartis.com. All submissions must be received no later than December 21, 2018. For more information about the STEP Program, please see the program backgrounder and submission FAQ. About Novartis Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis References
Novartis Media Relations
Novartis Investor Relations
View original content:http://www.prnewswire.com/news-releases/novartis-to-fund-five-innovative-ideas-to-support-patients-and-the-sickle-cell-community-300749863.html SOURCE Novartis |